Literature DB >> 7236714

Adsorption to fibrin of native fragments of known primary structure from human plasminogen.

S Thorsen, I Clemmensen, L Sottrup-Jensen, S Magnusson.   

Abstract

Limited proteolysis of native Glu-plasminogen with pancreatic elastase produced three major fragments, K1+2#3, K4, K5-light chain (miniplasminogen). Fibrin-binding was determined by clotting fibrinogen in the presence of 125I-labelled fragments and measuring 125I in the washed fibrin and in the supernatant. Of the fragments miniplasminogen showed the highest fibrin-binding, the strength of which was intermediate between those of Glu-plasminogen and Lys-plasminogen. The fibrin-binding of all three fragments was decreased by 6-aminohexanoic acid or tranexamic acid. This decrease was most pronounced with K1+2+3. The fibrin-binding of K1+2+3, but not that of K4 and miniplasminogen was decreased by alpha 2-antiplasmin. The fibrin-binding of K1+2+3 and mini-plasminogen was lower in a plasma clot than in a purified fibrin clot. Our results indicate that each of the three fragments can bind to fibrin. They confirm that an alpha 2-antiplasmin-binding site is located on K1+2+3. Furthermore two of the fragments, namely K4 and K1+2+3 contain lysine-binding site(s).

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7236714     DOI: 10.1016/0005-2795(81)90171-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  22 in total

1.  An Inhibitor of the F1 subunit of ATP synthase (IF1) modulates the activity of angiostatin on the endothelial cell surface.

Authors:  Nick R Burwick; Miriam L Wahl; Jun Fang; Zhaoxi Zhong; Tammy L Moser; Bo Li; Roderick A Capaldi; Daniel J Kenan; Salvatore V Pizzo
Journal:  J Biol Chem       Date:  2004-11-04       Impact factor: 5.157

2.  Stopped-flow fluorescence kinetics of bovine alpha 2-antiplasmin inhibition of bovine midiplasmin.

Authors:  S Christensen; L Sottrup-Jensen; U Christensen
Journal:  Biochem J       Date:  1995-01-01       Impact factor: 3.857

3.  Localization of the binding site of tissue-type plasminogen activator to fibrin.

Authors:  A Ichinose; K Takio; K Fujikawa
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

4.  In vivo regulation of plasminogen function by plasma carboxypeptidase B.

Authors:  Carmen M Swaisgood; Detlef Schmitt; Dan Eaton; Edward F Plow
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

5.  Zymogen-activation kinetics. Modulatory effects of trans-4-(aminomethyl)cyclohexane-1-carboxylic acid and poly-D-lysine on plasminogen activation.

Authors:  L C Petersen; J Brender; E Suenson
Journal:  Biochem J       Date:  1985-01-01       Impact factor: 3.857

6.  Interaction of amorphous calcium phosphate with fibrin in vitro causes decreased fibrinolysis and altered protease profiles: implications for atherosclerotic disease.

Authors:  G S Makowski; M L Ramsby
Journal:  Inflammation       Date:  2001-10       Impact factor: 4.092

7.  Sequence of formation of molecular forms of plasminogen and plasmin-inhibitor complexes in plasma activated by urokinase or tissue-type plasminogen activator.

Authors:  S Thorsen; S Müllertz; E Suenson; P Kok
Journal:  Biochem J       Date:  1984-10-01       Impact factor: 3.857

8.  Macro- and micro-stabilities of the kringle 4 domain from plasminogen. The effect of ligand binding.

Authors:  A De Marco; A Motta; M Llinás; R A Laursen
Journal:  Biophys J       Date:  1985-09       Impact factor: 4.033

9.  The AH-site of plasminogen and two C-terminal fragments. A weak lysine-binding site preferring ligands not carrying a free carboxylate function.

Authors:  U Christensen
Journal:  Biochem J       Date:  1984-10-15       Impact factor: 3.857

10.  Role of Intravenous Tranexamic Acid on Caesarean Blood Loss: A Prospective Randomised Study.

Authors:  Irene Ray; Ratneshwar Bhattacharya; Somajita Chakraborty; Chiranjib Bagchi; Sima Mukhopadhyay
Journal:  J Obstet Gynaecol India       Date:  2016-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.